Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow up

Simple item page
dc.contributor.authorMarcellin, Patrick
dc.contributor.authorPiratvisuth, Teerha
dc.contributor.authorBrunetto, Maurizia
dc.contributor.authorBonino, F.
dc.contributor.authorLau, George
dc.contributor.authorFarci, Patrizia
dc.contributor.authorYurdaydın, Cihan
dc.contributor.authorWu, J.
dc.contributor.authorPopescu, Matei
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.tr_TR
dc.date.accessioned2022-06-09T05:58:02Z
dc.date.available2022-06-09T05:58:02Z
dc.date.issued2009
dc.descriptionBu çalışma, 22-26 Nisan 2009 tarihleri arasında Copenhagen[Danimarka]’da düzenlenen 44. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipEuropean Assoc Study Liveren_US
dc.identifier.citationMarcellin, P. vd. (2009) "Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow up". Journal of Hepatology, 50(Supplement 1), S336-S336.en_US
dc.identifier.endpageS336tr_TR
dc.identifier.issn0168-8278
dc.identifier.issueSupplement 1en_US
dc.identifier.startpageS336tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/26980
dc.identifier.volume50tr_TR
dc.identifier.wos000266384701407tr_TR
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.journalJournal of Hepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleIncreasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow upen_US
dc.typeArticle
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science